- Home
- Latest
- By speciality
- Biology
- Bone
- Brain and nervous system
- Breast
- Colorectal and gastrointestinal
- Community
- Diagnostics
- Drug development
- Epidemiology and prevention
- Haematology oncology
- Head and neck
- Hepatobiliary pancreatic
- Lung and pleura
- Melanoma and skin
- Ovary and gynaecology
- Paediatric
- Prostate and urology
- Psycho social
- Radiotherapy
- Sarcomas
- Surgery
- Other
- By congress
- By continent
- Latest technologies
- Most viewed
- Archive
- Contact us
- FAQ's
- Register
ASCO 2009, Colorectal and gastrointestinal, North America
Flash player required
You do not have the correct version of the flash player required to view this content. Click here to install the free Adobe flash player.
Dr Norman Wolmark - Chairman Dept of Human Oncology, Allegheny General Hospital, US
ASCO: Bevacizumab and standard adjuvant chemotherapy: no improvement in disease-free survival for early-stage colon cancer
ASCO press conference: Adding bevacizumab (avastin) to standard adjuvant chemotherapy does not improve disease-free survival for early-stage colon cancer
Specialities
- Biology (58)
- Bone (16)
- Brain and nervous system (14)
- Breast (143)
- Colorectal and gastrointestinal (32)
- Community (61)
- Diagnostics (27)
- Drug development (49)
- Epidemiology and prevention (42)
- Haematology oncology (39)
- Head and neck (17)
- Hepatobiliary pancreatic (15)
- Lung and pleura (30)
- Melanoma and skin (22)
- Ovary and gynaecology (29)
- Paediatric (17)
- Prostate and urology (32)
- Psycho social (19)
- Radiotherapy (18)
- Sarcomas (13)
- Surgery (24)
Content is the view and comment of the speakers or author and not of sponsoring companies or organisations. Organisation logo does not indicate endorsement.
Comments on this video Report unsuitable comment
No comments have been made on this video yet, be the first to voice your opinion, use the form on the right.
Add a comment